Cargando…

Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models

BACKGROUND: To validate and compare various MRI-based radiomics models to evaluate treatment response to neoadjuvant chemoradiotherapy (nCRT) of rectal cancer. METHODS: A total of 80 patients with locally advanced rectal cancer (LARC) who underwent surgical resection after nCRT were enrolled retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhihui, Ma, Xiaolu, Shen, Fu, Lu, Haidi, Xia, Yuwei, Lu, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885409/
https://www.ncbi.nlm.nih.gov/pubmed/33593304
http://dx.doi.org/10.1186/s12880-021-00560-0
_version_ 1783651599229386752
author Li, Zhihui
Ma, Xiaolu
Shen, Fu
Lu, Haidi
Xia, Yuwei
Lu, Jianping
author_facet Li, Zhihui
Ma, Xiaolu
Shen, Fu
Lu, Haidi
Xia, Yuwei
Lu, Jianping
author_sort Li, Zhihui
collection PubMed
description BACKGROUND: To validate and compare various MRI-based radiomics models to evaluate treatment response to neoadjuvant chemoradiotherapy (nCRT) of rectal cancer. METHODS: A total of 80 patients with locally advanced rectal cancer (LARC) who underwent surgical resection after nCRT were enrolled retrospectively. Rectal MR images were scanned pre- and post-nCRT. The radiomics features were extracted from T2-weighted images, then reduced separately by least absolute shrinkage and selection operator (LASSO) and principal component analysis (PCA). Four classifiers of Logistic Regression, Random Forest (RF), Decision Tree and K-nearest neighbor (KNN) models were constructed to assess the tumor regression grade (TRG) and pathologic complete response (pCR), respectively. The diagnostic performances of models were determined with leave-one-out cross-validation by generating receiver operating characteristic curves and decision curve analysis. RESULTS: Three features related to the TRG and 11 features related to the pCR were obtained by LASSO. Top five principal components representing a cumulative contribution of 80% to overall features were selected by PCA. For TRG, the area under the curve (AUC) of RF model was 0.943 for LASSO and 0.930 for PCA, higher than other models (P < 0.05 for both). As for pCR, the AUCs of KNN for LASSO and PCA were 0.945 and 0.712, higher than other models (P < 0.05 for both). The DCA showed that LASSO algorithm was clinically superior to PCA. CONCLUSION: MRI-based radiomics models demonstrated good performance for evaluating the treatment response of LARC after nCRT and LASSO algorithm yielded more clinical benefit.
format Online
Article
Text
id pubmed-7885409
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78854092021-02-17 Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models Li, Zhihui Ma, Xiaolu Shen, Fu Lu, Haidi Xia, Yuwei Lu, Jianping BMC Med Imaging Original Research BACKGROUND: To validate and compare various MRI-based radiomics models to evaluate treatment response to neoadjuvant chemoradiotherapy (nCRT) of rectal cancer. METHODS: A total of 80 patients with locally advanced rectal cancer (LARC) who underwent surgical resection after nCRT were enrolled retrospectively. Rectal MR images were scanned pre- and post-nCRT. The radiomics features were extracted from T2-weighted images, then reduced separately by least absolute shrinkage and selection operator (LASSO) and principal component analysis (PCA). Four classifiers of Logistic Regression, Random Forest (RF), Decision Tree and K-nearest neighbor (KNN) models were constructed to assess the tumor regression grade (TRG) and pathologic complete response (pCR), respectively. The diagnostic performances of models were determined with leave-one-out cross-validation by generating receiver operating characteristic curves and decision curve analysis. RESULTS: Three features related to the TRG and 11 features related to the pCR were obtained by LASSO. Top five principal components representing a cumulative contribution of 80% to overall features were selected by PCA. For TRG, the area under the curve (AUC) of RF model was 0.943 for LASSO and 0.930 for PCA, higher than other models (P < 0.05 for both). As for pCR, the AUCs of KNN for LASSO and PCA were 0.945 and 0.712, higher than other models (P < 0.05 for both). The DCA showed that LASSO algorithm was clinically superior to PCA. CONCLUSION: MRI-based radiomics models demonstrated good performance for evaluating the treatment response of LARC after nCRT and LASSO algorithm yielded more clinical benefit. BioMed Central 2021-02-16 /pmc/articles/PMC7885409/ /pubmed/33593304 http://dx.doi.org/10.1186/s12880-021-00560-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Original Research
Li, Zhihui
Ma, Xiaolu
Shen, Fu
Lu, Haidi
Xia, Yuwei
Lu, Jianping
Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models
title Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models
title_full Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models
title_fullStr Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models
title_full_unstemmed Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models
title_short Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models
title_sort evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various mri-based radiomics models
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885409/
https://www.ncbi.nlm.nih.gov/pubmed/33593304
http://dx.doi.org/10.1186/s12880-021-00560-0
work_keys_str_mv AT lizhihui evaluatingtreatmentresponsetoneoadjuvantchemoradiotherapyinrectalcancerusingvariousmribasedradiomicsmodels
AT maxiaolu evaluatingtreatmentresponsetoneoadjuvantchemoradiotherapyinrectalcancerusingvariousmribasedradiomicsmodels
AT shenfu evaluatingtreatmentresponsetoneoadjuvantchemoradiotherapyinrectalcancerusingvariousmribasedradiomicsmodels
AT luhaidi evaluatingtreatmentresponsetoneoadjuvantchemoradiotherapyinrectalcancerusingvariousmribasedradiomicsmodels
AT xiayuwei evaluatingtreatmentresponsetoneoadjuvantchemoradiotherapyinrectalcancerusingvariousmribasedradiomicsmodels
AT lujianping evaluatingtreatmentresponsetoneoadjuvantchemoradiotherapyinrectalcancerusingvariousmribasedradiomicsmodels